Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours Β· Estimated delivery Aug 15 - Aug 20
A pharmacy operating under USP 797 Category 3 conditions with validated stability data can assign longer BUDs
This can lead to decreased endurance and slower recovery
As an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, retatrutide is currently undergoing Phase 3 clinical trials for obesity and type 2 diabetes
It is a research-use-only catalog item, kept in cold storage and offered as a single vial or a discounted 10-vial kit that ships from within Canada
Each vial contains 5mg of research material supplied in a sealed laboratory vial with tamper evident protection and individual batch identification for traceability purposes
Do the New Obesity Drugs Pay for Themselves
US$ 26.56
US$ 28.39
US$ 27.44
US$ 27.73
